Medical doctor who realised how to scale up UV inactivation for Rapid Response. Protein and PCR intact virus for next-gen vaccines, diagnostics, and biodefense.
RoLink Biotechnology is a Hungarian startup founded by two young medical doctors of the National Laboratory of Virology transforming pandemic preparedness with a proprietary UV-inactivation technology that renders viruses non-infectious while preserving 100% of their structure. This enables safer, faster, and more cost-effective R&D, diagnostics, and vaccine development—cutting OPEX by up to 90%. Operating in the same team and partnership with Central Europe’s only university-based BSL-4 lab, RoLink combines startup agility with top-tier infrastructure. Integrated into EDF rapid response programs, RoLink is led by founders Dr. Roland Hetényi and Dr. Dániel Hanna (former medical school classmates) experts in virology, and vaccine development, and purification, successful history of clinical study, backed by an ex-BCG consultant, an IP expert, and national biodefense experts.
I’m Dr. Roland Hetényi, a medical researcher specializing in virology, immunology, and vaccine development. I currently work at the Virological National Laboratory of the University of Pécs and the National Blood Service's R&D Directorate. I also lead RoLink Biotechnology Ltd. as managing director, driving innovative biotech projects. I earned my MD cum laude from the University of Pécs in 2020 and am now pursuing my PhD in pharmaceutical sciences. My main research interests include virus purification, UV inactivation, and immune responses. I'm passionate about science communication and regularly engage in outreach and education.